Advancing Voluntary, Informed Consent to Medical Intervention

Eli Lilly Paid Mass Shooting Victims Hush Money in Prozac Lawsuit

The “norm and practice” of Pharmaceutical companies is to vehemently deny the most serious adverse side effects of their products. This industry’s success in concealing the truth about the serious harm caused by their drugs and vaccines has been aided and abetted . . . Continue reading →

NYU Medical School Shut Down Eight Studies in Psychiatry

On June 27, 2016, The New York Times reported that New York University medical school “quietly shut down eight studies at its prominent psychiatric research center” and dismissed Dr. Alexander Neumeister, the studies’ lead investigator was the director of the Molecular Imaging . . . Continue reading →

Military Polypharmacy, PTSD: Deaths

"The problem of prescription overdose in the military has its parallel in civilian life. The tragic overdose victims in both spheres represent canaries in the coal mine–only the most obvious victims of what has become our national orgy of over using psychotropic drugs."  Allen Frances MD Continue reading →

FDA Expands Market for Another Toxic Antipsychotic

According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic antipsychotic drug, Saphris, for treating acute manic-depressive behavior in adults. Antipsychotics (neuroleptics) are a controversial class of drugs: Risperdal (approved in 1993), Zyprexa (1994), Seroquel . . . Continue reading →